Safety of GnRH agonists and antagonists

By Tarlatzis Basil C   Bili Helen  

Expert Opinion on Drug Safety, Vol. 3, Iss. 1, 2004-01 ,pp. : 39-46

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

By  

Current Cancer Drug Targets, Vol. 6, Iss. 3, 2006-05 ,pp. : 257-269

Bentham Science Publishers

Access to resources Recommend Favorite

GnRH antagonists in IVF

By Kolibianakis Efstratios M   Tarlatzis Basil   Devroey Paul  

Reproductive BioMedicine Online, Vol. 10, Iss. 6, 2005-06 ,pp. : 705-712

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS

By Vrtačnik-Bokal Eda   Virant Klun Irma   Verdenik Ivan  

Reproductive BioMedicine Online, Vol. 18, Iss. 1, 2009-01 ,pp. : 21-28

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Semi-Mechanistic Pharmacodynamic Modeling for Degarelix, a Novel Gonadotropin Releasing Hormone (GnRH) Blocker

By Jadhav Pravin   Agersø Henrik   Tornøe Christoffer   Gobburu Jogarao  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 5, 2006-10 ,pp. : 609-634

Springer Publishing Company

Access to resources Recommend Favorite